CRGX - CARGO Therapeutics, Inc.

4.47
-0.070   -1.566%

Share volume: 10,919,722
Last Updated: 08-18-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$4.54
-0.07
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
33%
Profitability 35%
Dept financing 21%
Liquidity 50%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
14.03%
2 Year
-85.01%
Key data
Stock price
$4.47
P/E Ratio 
0.00
DAY RANGE
$4.46 - $4.53
EPS 
-$4.62
52 WEEK RANGE
$3.58 - $4.77
52 WEEK CHANGE
$7.71
MARKET CAP 
187.433 M
YIELD 
N/A
SHARES OUTSTANDING 
46.113 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
BETA 
2.64
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Gina Chapman
Region: US
Website: cargo-tx.com
Employees: 0
IPO year: 2023
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

We are a clinical-stage biotechnology company uniquely positioned to advance next generation, potentially curative cell therapies for cancer patients. We changed our name to CARGO Therapeutics, Inc. in September 2022. Our principal executive offices are located at 1900 Alameda De Las Pulgas, Suite 350, San Mateo, California.

Recent news